DSpace Repository

Browsing by Author "Alland, D."

Browsing by Author "Alland, D."

Sort by: Order: Results:

  • Clinical research and development of tuberculosis diagnostics: Moving from silos to synergy 
    Nahid, P.; Kim, P.S.; Evans, Carlton Anthony William; Alland, D.; Barer, M.; Diefenbach, J.; Ellner, J.; Hafner, R.; Hamilton, C.D.; Iademarco, M.F.; Ireton, G.; Kimerling, M.E.; Lienhardt, C.; MacKenzie, W.R.; Murray, M.; Perkins, M.D.; Posey, J.E.; Roberts, T.; Sizemore, C.; Stevens, W.S.; Via, L.; Williams, S.D.; Yew, W.W.; Swindells, S. (Oxford University Press, 2012)
    The development, evaluation, and implementation of new and improved diagnostics have been identified as critical needs by human immunodeficiency virus (HIV) and tuberculosis researchers and clinicians alike. These needs ...
  • Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears 
    Rowneki, M.; Aronson, N.; Du, P.; Sachs, P.; Blakemore, R.; Chakravorty, S.; Levy, S.; Jones, A.L.; Trivedi, G.; Chebore, S.; Addo, D.; Byarugaba, D.K.; Njobvu, P.D.; Wabwire-Mangen, F.; Erima, B.; Ramos, E.S.; Evans, Carlton Anthony William; Hale, B.; Mancuso, J.D.; Alland, D. (Public Library of Science, 2020)
    Background: Drug susceptibility testing for Mycobacterium tuberculosis (MTB) is difficult to perform in resource-limited settings where Acid Fast Bacilli (AFB) smears are commonly used for disease diagnosis and monitoring. ...
  • Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study 
    Boehme, C.C.; Nicol, M.P.; Nabeta, P.; Michael, J.S.; Gotuzzo Herencia, José Eduardo; Tahirli, R.; Gler, M.T.; Blakemore, R.; Worodria, W.; Gray, C.; Huang, L.; Cáceres Nakiche, Tatiana; Mehdiyev, R.; Raymond, L.; Whitelaw, A.; Sagadevan, K.; Alexander, H.; Albert, H.; Cobelens, F.; Cox, H.; Alland, D.; Perkins, M.D. (Elsevier, 2011)
    The Xpert MTB/RIF test (Cepheid, Sunnyvale, CA, USA) can detect tuberculosis and its multidrug-resistant form with very high sensitivity and specificity in controlled studies, but no performance data exist from district ...
  • A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay 
    Blakemore, R.; Nabeta, P.; Davidow, A.L.; Vadwai, V.; Tahirli, R.; Munsamy, V.; Nicol, M.; Jones, M.; Persing, D.H.; Hillemann, D.; Ruesch-Gerdes, S.; Leisegang, F.; Zamudio Fuertes, Carlos Eduardo; Rodrigues, C.; Boehme, C.C.; Perkins, M.D.; Alland, D. (American Thoracic Society, 2011)
    Rationale: The Xpert MTB/RIF is an automated molecular test for Mycobacterium tuberculosis that estimates bacterial burden by measuring the threshold-cycle (Ct) of its M. tuberculosis-specific real-time polymerase chain ...
  • Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure 
    Jayakumar, A.; Savic, R. M.; Everett, C. K.; Benator, D.; Alland, D.; Heilig, C. M.; Weiner, M.; Friedrich, S. O.; Martinson, N. A.; Kerrigan, A.; Zamudio Fuertes, Carlos Eduardo; Goldberg, S. V.; Whitworth, W. C.; Davis, J. L.; Nahid, P. (American Society for Microbiology, 2016)
    The Xpert MTB/RIF assay is both sensitive and specific as a diagnostic test. Xpert also reports quantitative output in cycle threshold (CT) values, which may provide a dynamic measure of sputum bacillary burden when used ...

Search DSpace

Browse

My Account